XML 17 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Unaudited Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (2,049,885) $ (7,462,574)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 145,218 12,226
Share-based compensation 765,136 1,348,310
Non-cash interest expense 185,139 664,865
Change in fair value of warrant liability (7,017,923) (1,998,878)
Provision for obsolete inventory 770,619
Expenses allocated to warrant liability 1,302,995
Deferred tax benefit (920,000)
Changes in operating assets and liabilities    
Accounts receivable (22,107) (51,636)
Inventory (524,245) (255,806)
Vendor deposits 629,353 (247,050)
Prepaid expenses and other assets (170,356) (249,037)
Accounts payable and accrued liabilities 55,405 (10,064)
Accrued bonus and severance (94,629)
Accrued interest 166,442 173,230
Accrued interest - related parties 13,747
Other long-term liabilities (50,406) 68,415
Net cash used in operating activities (7,212,239) (7,611,257)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchases of property and equipment (654,870) (198,779)
Cash received in business combination 11,776,427
Net cash provided by (used in) investing activities (654,870) 11,577,648
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from issuance of convertible notes payable 460,000
Proceeds from issuance of convertible notes payable - related parties 108,300
Proceeds from Dipexium note 2,000,000
Proceeds from issuance of term loan and warrants, net of allocated issuance costs 7,145,584
Proceeds from equity offering, net of allocated issuance costs 16,698,854
Net cash provided by financing activities 26,412,738
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (7,867,109) 30,379,129
Cash and cash equivalents, beginning of period 24,404,368 59,335
Cash and cash equivalents, end of period 16,537,259 30,438,464
SUPPLEMENTAL INFORMATION    
Income taxes
Interest 497,136 39,531
NON-CASH INVESTING AND FINANCING TRANSACTIONS    
Accounts payable for purchases of property and equipment 285,610
Value of common shares issued to vendors for services 67,500 37,500
Equity offering proceeds allocated to warrant liability 15,876,546
Term loan proceeds allocated to warrants 318,398
Issuance of common shares for business combination 15,048,883
Issuance of common shares upon conversion of debt and accrued interest $ 2,495,630